Key Takeaways Organon completed the JADA System sale to Laborie for up to $465M, with 100 employees to transfer.OGN plans to use net proceeds for debt reduction, supporting its goal to lower net debt to adjusted EBITDA.OGN's JADA System aided 136,000 women in more than 20 countries; the deal values it at 6.5X TTM revenues.Organon & Co. (OGN) announced the completion of the divestiture of its JADA System to Laborie Medical Technologies Corp. The deal is worth up to $465 million, including $440 million paid a ...

Key Takeaways OGN received FDA approval extending NEXPLANON's contraceptive use from three years to up to five years.Trial data show no pregnancies in years four and five, showing efficacy across a wide range of BMIs.The approval introduces a new REMS program to certify providers for proper insertion and removal.Organon & Co. (OGN) recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of use of NEXPLANON (etonogestrel implant) 68 mg Radiopaque to up to five ...